MD Anderson has numerous presentations at the 2026 SSO Annual Meeting. All times listed in Mountain Time.
MD Anderson has numerous presentations at the 2026 SSO Annual Meeting. All times listed in Mountain Time.
Wednesday, March 4
Pre-course: Surgical clinical trials primer: Designing your study (non-CME)
8 a.m.–12:30 p.m.
Why trials fail: Beyond just sample size
10:45–11:05 a.m.
Faculty: Beth Helmink, M.D., Ph.D.
Thursday, March 5
Breast great debate
8:55–9:55 a.m.
Debate #1: When clinical trials answer only one piece of the puzzle: How should multidisciplinary teams implement partial evidence in locoregional breast cancer management — Con
9:08–9:18 a.m.
Faculty: Simona Shaitelman, M.D.
Debate #1: Rebuttal — Con
9:20–9:22 a.m.
Faculty: Simona Shaitelman, M.D.
Debate # 2: Should pCR allow us to omit surgery? — Pro
9:24–9:31 a.m.
Faculty: Helen Johnson, M.D.
Debate # 2: Rebuttal — Pro
9:39–9:40 a.m.
Faculty: Helen Johnson, M.D.
HPB great debate: Histotripsy for liver malignancies: Breakthrough or hype?
8:55–9:55 a.m.
Moderator: Hop Tran Cao, M.D.
Poster park showcase
10–10:30 a.m.
PPS8. Advanced clinical T category and high tumor grade independently predict worse survival among rectal cancer patients undergoing organ preservation
Presenter: Stephanie Keeling, M.D.
PPS11. Empty pelvis syndrome after beyond total mesorectal excision (bTME) for rectal cancer: Impact of surgical complexity and flap reconstruction
Presenter: Jessica Lie, M.D.
PPS16. Risk of ovarian metastasis in colorectal cancer-related carcinomatosis
Presenter: Ryan Morgan, M.D.
PPS17. Predicting regional lymph node metastasis in goblet cell adenocarcinoma of the appendix using an internally validated model: Can a right hemicolectomy be omitted?
Presenter: Sara Ginzberg, M.D.
PPS18. Evaluating peritoneal washing supernatant NGS integration to inform staging of peritoneal metastases
Presenter: Taylor Neilson, M.D.
2025 American Thyroid Association differentiated thyroid cancer guidelines: What is new? A surgical summary
10:30 a.m.–12 p.m.
Moderator: Sarah Fisher, M.D.
Panel with case discussions to facilitate real-world application of the guidelines
11:17–11:57 a.m.
Faculty: Elizabeth Grubbs, M.D.
Abstract presentations: Breast I
10:30 a.m.–12 p.m.
P8. Primary breast angiosarcoma: Clinicopathologic features and oncologic outcomes
11:21–11:28 a.m.
Presenter: Rick Vavolizza, M.D.
High quality cancer surgery: Past, present, and future of operative standards for cancer surgery (Non-CME)
10:35–11:35 a.m.
Moderator: Tim Vreeland, M.D.
Abstract presentations: PSM
1:55–3:25 p.m.
Moderator: Beth Helmink, M.D., Ph.D.
Early-onset colorectal cancer: Epidemiology, genetics, and evolving management (non-CME)
4–5 p.m.
Screening, prevention, and future directions in early-onset colorectal cancer
4:36–4:47 p.m.
Faculty: Nancy You, M.D.
Friday, March 6
Management across the pancreatic adenocarcinoma continuum: From precursors to metastases
8–9:30 a.m.
Oligometastases: Whether treatment should be expanded to surgery
8:47–9:02 a.m.
Faculty: Matthew Katz, M.D.
Patient-centered rectal cancer care
8–9:30 a.m.
Moderator: Josh Smith, M.D., Ph.D.
Sequencing — chemotherapy or radiation first for LARC? And why?
8:27–8:39 a.m.
Faculty: Nancy You, M.D.
SSO awards assembly
10:20–10:50 a.m.
Charles M. Balch Distinguished Service Award
10:20–10:30 a.m.
Recipient: Peter Pisters, M.D.
Bridging the gap: Developing APPs from new hire to independent practitioners in surgical oncology (non-CME)
1–2 p.m.
Moderator: Steven Wei, Ed.D.
Expanding impact: APP transition to independent practice: APP role utilization and how to optimize success through APP independent practice clinics
1:25–1:35 p.m.
Faculty: Rae Reynolds, Ph.D.
Great debate: Controversies in the management of gastroesophageal junction (GEJ) cancers
2:35–3:35 p.m.
Debate #2: Surgery Should Not Be Omitted
3:17–3:27 p.m.
Faculty: Brian Badgwell, M.D.
Debate #2: Rebuttal — Surgery should not be omitted
3:30–3:33 p.m.
Faculty: Brian Badgwell, M.D.
Abstract presentations: Quality/disparities
2:35–3:35 p.m.
P88. Prospective evaluation of safety and patient satisfaction with apixaban versus low molecular weight heparin for extended prophylaxis after cancer surgery
3:26–3:33 p.m.
Presenter: Alexandra Adams, M.D.
Poster park showcase
3:40–4:10 p.m.
PPS38. Circulating tumor DNA dynamics in neoadjuvant therapy response: A prospective study in inflammatory breast cancer patients
Presenter: Megan McClanahan, M.D.
HUB zone presentations: Breast podcast recap: Invasive lobular carcinoma (Non-CME)
3:45–4:05 p.m.
Moderator: Taiwo Adesoye, M.D.
HUB zone presentations: Trial in progress: Immuno-oncology (Non-CME)
3:45–4:05 p.m.
TIP3. A prospective feasibility study using preoperative ctDNA to tailor neoadjuvant chemotherapy for patients with colorectal or appendiceal adenocarcinoma
3:55–3:59 p.m.
Presenter: Ryan Morgan, M.D.
HUB zone presentations: Trial in progress: Pan-tumor (Non-CME)
3:45–4:05 p.m.
TIP6. Metronidazole to optimize the microbiome of patients with rectal adenocarcinoma undergoing neoadjuvant therapy: protocol for the phase II MONARCH trial
3:51–3:55 p.m.
Presenter: Laurence Diggs, M.D.
Colorectal great debates
4:15–5:15 p.m.
Moderator: Ramy Behman, M.D., Ph.D.
Saturday, March 7
Abstract presentations: Breast II
8:30–10 a.m.
P112. Clipped node pathology as a guide for limited axillary surgery in occult breast cancer
9:49–9:56 a.m.
Presenter: Courtney Lattimore, M.D.
ctDNA in GI surgical oncology — game changer or prognostic gimmick?
10:30 a.m.–12 p.m.
Clinical implications of ctDNA in locoregional colorectal cancer
10:35–10:47 a.m.
Faculty: Nancy You, M.D.
Abstract presentations: Top-rated videos
10:30 a.m.–12 p.m.
V2. Robotic proximal gastrectomy with double tract reconstruction and distal pancreatectomy with splenectomy for gastroesophageal junction tumor
10:40–10:49 a.m.
Presenter: Anneliese Hierl, M.D.
Give Now
Your gift will help make a tremendous difference.
Research Areas
Find out about the four types of research taking place at MD Anderson.
Subscribe
Get the latest information on our cancer breakthroughs.